Plasma transforming growth factor β1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B

Regulatory Peptides

Volumn 131, Issue 1-3, 2005, Pages 54-58

  Flisiak, Robert ^a   Jaroszewicz, Jerzy ^a   Łapiński, Tadeusz W ^a   Flisiak, Iwona ^a   Rogalska, Magdalena ^a   Prokopowicz, Danuta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Hepatitis; Liver; MMP; TGF ; TIMP

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; METALLOPROTEINASE; METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; EVALUATION; EXTRACELLULAR MATRIX; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; JAUNDICE; LIVER CELL DAMAGE; LIVER FUNCTION TEST; LIVER INJURY; MALE; MEASUREMENT; METABOLISM; PATIENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VIRUS HEPATITIS;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATOCYTES; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; STATISTICS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

HEPATITIS B VIRUS;

EID: 25844454803     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2005.06.002     Document Type: Article

References (31)

1. R. Flisiak, J. Li, E. Baraona, and C.S. Lieber Effects of ethanol on prostanoids production by liver fat-storing cells Hepatology 18 1993 153 159
2. A.M. Gressner, R. Weiskirchen, K. Breitkopf, and S. Dooley Roles of TGF-beta in hepatic fibrosis Front Biosci 7 2002 793 807
3. E.R. Garcia-Trevijano, M.J. Iraburu, L. Fontana, J.A. Dominguez-Rosales, A. Auster, and A. Cavarrubias-Pinedo Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta- dependent mechanism in rat hepatic stellate cells Hepatology 29 1999 960 970
4. M. Pinzani, and F. Marra Cytokine receptors and signaling in hepatic stellate cells Semin Liver Dis 21 2001 397 416
5. 1 J Hepatol 30 1999 48 60
6. T. Nakamura, C. Ushiyama, S. Suzuki, N. Shimada, I. Ebihara, and M. Suzaki Effect of plasma exchange on serum tissue inhibitor of metalloproteinase 1 and cytokine concentrations in patients with fulminant hepatitis Blood Purif 18 2000 50 54
7. M. Koulentaki, V. Valatas, K. Xidakis, A. Kouroumalis, E. Petinaki, and E. Castanas Matrix metalloproteinases and their inhibitors in acute viral hepatitis J Viral Hepatitis 9 2002 189 193
8. G.J. Prud'homme, and C.A. Piccirillo The inhibitory effects of transforming growth factor-beta-1 (TGF-β1) in autoimmune disease J Autoimmun 14 2000 23 42
9. N. Fausto Liver regeneration J Hepatol 32 2000 19 31
10. J.I. Leu, M.A. Crissey, and R. Taub Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice J Clin Invest 111 2003 129 139
11. J. Pan, M. Clayton, and M.A. Feitelson Hepatitis B virus X antigen promotes transforming growth factor-beta1 (TGF-beta1) activity by up-regulation of TGF-beta1 and down-regulation of alpha2-macroglobulin J Gen Virol 85 2004 275 282
12. K.H. Boeker, C.I. Haberkorn, D. Michels, P. Flemming, M.P. Manns, and R. Lichtinghagen Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C Clin Chim Acta 316 2002 71 81
13. 1 as an indicator of hepatic function impairment in liver cirrhosis Cytokine 12 2000 677 681
14. 1-possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis Hepato-gastroenterology 49 2002 1369 1372
15. 1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B World J Gastroenterol 10 2004 2661 2665
16. L.G. Lu, M.D. Zeng, M.B. Wan, C.Z. Li, Y.M. Mao, and J.Q. Li Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters World J Gastroenterol 9 2003 2574 2578
17. Y. Murawaki, Y. Ikuta, Y. Idobe, and H. Kawasaki Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis J Gastroenterol Hepatol 14 1999 138 145
18. Q.H. Nie, G.R. Duan, X.D. Luo, Y.M. Xie, H. Luo, Y.X. Zhou, and B.R. Pan Expression of TIMP-1 and TIMP-2 in rats with hepatic fibrosis World J Gastroenterol 10 2004 86 90
19. T. Ninomiya, S. Yoon, H. Nagano, Y. Kumon, Y. Seo, and M. Kasuga Significance of serum matrix metalloproteinases and their inhibitors on the antibibrogenetic effect of interferon-alfa in chronic hepatitis C patients Intervirology 44 2001 227 231
20. K.M. Walsh, P. Timms, S. Campbell, R.N. MacSween, and A.J. Morris Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases-1 and-2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C; comparison using ROC analysis Dig Dis Sci 44 1999 624 630
21. B.B. Zhang, W.M. Cai, H.L. Weng, Z.R. Hu, J. Lu, and M. Zheng Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis World J Gastroenterol 9 2003 2490 2496
22. B. Saile, N. Matthes, T. Knittel, and G. Ramadori Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells Hepatology 30 1999 196 202
23. F.R. Murphy, R. Issa, X. Zhou, S. Ratnarajah, H. Nagase, and M.J. Arthur Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis J Biol Chem 277 2002 11069 11076
24. J. George, D. Roulot, V.E. Kateliansky, and D.M. Bissell In vivo inhibition of rat stellate cell activation by soluble transforming growth factor β type II receptor: a potential new therapy for hepatic fibrosis Proc Natl Acad Sci U S A 96 1999 12719 12724
25. T. Nakamura, R. Sakata, T. Ueno, M. Sata, and H. Ueno Inhibition of transforming growth factor β prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats Hepatology 32 2000 247 255
26. D. Roulot, A.M. Sevcsik, T. Coste, A.D. Strosberg, and S. Marullo Role of transforming growth factor β type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats Hepatology 29 1999 1730 1738
27. D.J. Grainger, D.E. Mosedale, and J.C. Metcalfe TGF-β in blood: a complex problem Cytokine Growth Factor Rev 11 2000 133 145
28. Y. Miwa, A.J. Ellis, R.D. Hughes, P.G. Langley, J.A. Wendon, and R. Williams Effect of ELAD liver support on plasma HGF and TGF-beta 1 in acute liver failure Int J Artif Organs 19 1996 240 244
29. M. Date, K. Matsuzaki, M. Matsushita, Y. Tahashi, F. Furukawa, and K. Inoue Modulation of transforming growth factor beta function in hepatocytes and hepatic stellate cells in rat liver injury Gut 46 2000 719 724
30. J.J. Letterio, and A.B. Roberts Regulation of immune responses by TGF-β Annu Rev Immunol 16 1998 137 161
31. K. Sakaguchi, M. Kitano, M. Nishimura, T. Senoh, T. Ohta, and M. Terao Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis Hepato-gastroenterology 51 2004 1780 1783